From Cell Phones to Tractors: The Right to Repair Movement Drives On — Regulatory Oversight Podcast
Innovation in Compliance: Exploring the Intersection of Compliance, Technology, and AI with Ben Sperry
Upping Your Game: Episode 1 – Meeting Hui Chen’s Challenge
Compliance Tip of the Day: AI and Compliance Education
Sunday Book Review: April 27, 2025, The Books on Business for May Edition
The Briefing: The Future of TV? A 2025 Digital Media Trends Analysis
Innovation in Compliance: Design-Centric Compliance Training with Karen Oddo
Daily Compliance News: April 10, 2025, The Dark Money Corruption Edition
The LathamTECH Podcast — Can RSUs Unlock Employee Equity?
A Guide to SEP: Standard Essential Patents for Tech Startups
FINCast Ep. 40 – 21st Century Financial Warfare: Technology, Economy, & National Security
Compliance Tip of the Day: Real-Time Compliance Scoring
Innovation in Compliance: Navigating AI Governance in 2025 with Christine Uri
2025 Perspectives in Private Equity: AI & Technology
AGG Talks: Women in Tech Law Podcast - Episode 5: How the Tech Industry Can Monitor Regulatory Changes Under the Trump Administration
The Growing Role of State AGs in AI Regulatory & Enforcement Issues — The Good Bot Podcast
Investment Opportunities in Italy's Tech Market
Legal Alert | Japan is Primed for Increased Foreign Direct Investment
Spotlight on Lightmatter, the Photonic (Super) Computing Company Ready to Power the AI Revolution
Wiley's 10 Key Trade Developments: Outbound Investments and CFIUS Review
The legal battles surrounding generative AI and copyright continue to escalate with prominent players in the Indian music industry now seeking to join an existing lawsuit against OpenAI, the creator of ChatGPT. On February...more
On January 13, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”) issued its Framework for Artificial Intelligence Diffusion, an Interim Final Rule revising the Export Administration Regulations...more
Navigating the complex landscape of drug discovery requires innovative strategies and interdisciplinary collaborations spanning biotechnology, pharmacology, medicine and engineering. As the cost of developing new drugs...more